Adam Kaplin
Psychiatry · Baltimore, MDNPI 1871530006
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $45,949 of the $61,730 with a category attached, or 74.4%. EMD Serono, Inc. accounts for 90.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $17,250 and has fallen 99.3% since, to $125 in 2025. Among psychiatry clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $1011.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$56K
- E.r. Squibb & Sons, L.L.C.$3K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$245
- AbbVie$221
- Alkermes, Inc.$125
Across 34 payments — averaging $17,609 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$531K
- Biogen$50K
- Sage Therapeutics, LLC$18K
What the payments were for
- Consulting fees$45,94974%
- Speaking & faculty fees$10,51017%
- Travel & lodging$3,4016%
- Food & beverage$1,8563%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 53 | $55,745 |
| E.r. Squibb & Sons, L.L.C. | 1 | $3,200 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $2,194 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $245 |
| AbbVie | 2 | $221 |
| Alkermes, Inc. | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$61,730 in reported general payments places this provider in the 95th percentile of 851 psychiatry providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KeppraLevetiracetam | 12 | $7,078 |
| Levetiracetam | 11 | $128 |
| Clonazepam | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Baltimore
- John VaethBaltimore$2.1M
- Scott AaronsonBaltimore$334K
- Robert LehmanBaltimore$140K
- Karen AndersonBaltimore$117K
- Orlando DavisBaltimore$104K
- Akira SawaBaltimore$69K
- Paul RosenbergBaltimore$66K
- Marc FishmanBaltimore$59K
- David NeubauerBaltimore$59K
- Chiadikaobi OnyikeBaltimore$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.